These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32782595)

  • 1. Long non-coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasion.
    Wang A; Meng J; Liu H; Li C; Zhou Z
    Oncol Lett; 2020 Sep; 20(3):2779-2787. PubMed ID: 32782595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated BCAR4 contributes to proliferation and migration of cervical cancer cells.
    Zou R; Chen X; Jin X; Li S; Ou R; Xue J; Yan X; Chen L; Hu Y; Zhu H
    Surg Oncol; 2018 Jun; 27(2):306-313. PubMed ID: 29937186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasis.
    Ju L; Zhou YM; Yang GS
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4445-4451. PubMed ID: 27874956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.
    Jiang J; Shi SH; Li XJ; Sun L; Ge QD; Li C; Zhang W
    Oncol Lett; 2018 Jun; 15(6):9543-9552. PubMed ID: 29805676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition.
    Li N; Gao WJ; Liu NS
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2075-2086. PubMed ID: 28537678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
    Chen F; Mo J; Zhang L
    Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Functional Role of Oncogenic LncRNA BCAR4 for Cancer Outcome.
    Wang B; Xu W; Cai Y; Liu K; Wu J; Guo C; Yuan C
    Curr Pharm Des; 2021; 27(39):4107-4113. PubMed ID: 34086548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer.
    Wang X; He H; Rui W; Xie X; Wang D; Zhu Y
    Onco Targets Ther; 2020; 13():2483-2490. PubMed ID: 32273720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling.
    Ouyang S; Zheng X; Zhou X; Chen Z; Yang X; Xie M
    Oncotarget; 2017 Nov; 8(54):92815-92826. PubMed ID: 29190958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers.
    Tu C; Ren X; He J; Zhang C; Chen R; Wang W; Li Z
    J Cancer; 2019; 10(24):5992-6002. PubMed ID: 31762809
    [No Abstract]   [Full Text] [Related]  

  • 12. BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance.
    Cai Z; Wu Y; Li Y; Ren J; Wang L
    Aging (Albany NY); 2018 Dec; 10(12):3702-3712. PubMed ID: 30513511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA BCAR4 promotes chondrosarcoma cell proliferation and migration through activation of mTOR signaling pathway.
    Shui X; Zhou C; Lin W; Yu Y; Feng Y; Kong J
    Exp Biol Med (Maywood); 2017 May; 242(10):1044-1050. PubMed ID: 28399646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-Coding RNA BCAR4 Promotes Growth, Invasion and Tumorigenicity by Targeting miR-2276 to Upregulate MMP7 Expression in Glioma.
    Wang Z; Wang L; Liang Z; Xi Y
    Onco Targets Ther; 2019; 12():10963-10973. PubMed ID: 31849498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA Breast cancer antiestrogen resistance 4 is associated with cancer progression and its significant prognostic value.
    Zhao W; Wang Z; Fang X; Li N; Fang J
    J Cell Physiol; 2019 Aug; 234(8):12956-12963. PubMed ID: 30537165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells.
    van Agthoven T; Dorssers LC; Lehmann U; Kreipe H; Looijenga LH; Christgen M
    PLoS One; 2015; 10(8):e0136845. PubMed ID: 26317614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer.
    Ouyang S; Zhou X; Chen Z; Wang M; Zheng X; Xie M
    Cancer Cell Int; 2019; 19():72. PubMed ID: 30962766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of targeted regulation of LATS2 by LncRNA BCAR4 on proliferation, migration and apoptosis of HCC cells.
    Huang Y; Rao X; Luo Y; Deng Y; Zhong C
    Am J Transl Res; 2021; 13(5):4624-4631. PubMed ID: 34150042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
    Cao W; Peng T; Zhou Y
    J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fusion of CD63-BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis.
    Bae K; Kim JH; Jung H; Kong SY; Kim YH; Kim S; Lee GK; Lee JS; Lee JJ; Ju YS; Choi YK; Yoon KA
    Br J Cancer; 2021 Jan; 124(1):290-298. PubMed ID: 33204025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.